Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Advantage Solutions Inc.ADV · Entity 5563 | Director | May 27, 2026 | May 29, 2026 |
| Conyers Park III Acquisition Corp.CPAA · Entity 135255 | Co-Chief Executive Officer | August 09, 2021 | August 10, 2021 |
| Nielsen Holdings plcNLSN · Entity 16431 | Director | June 16, 2017 | June 20, 2017 |
| PFIZER INCPFE · Entity 2863 | Director | September 25, 2020 | September 29, 2020 |
| Simply Good Foods CoSMPL · Entity 4946 | Director | April 23, 2026 | April 24, 2026 |
| UNIFI INCUFI · Entity 6574 | Director | October 27, 2021 | October 29, 2021 |
| Viatris IncVTRS · Entity 3277 | Director | March 06, 2026 | March 10, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Advantage Solutions Inc.
Report date May 27, 2026 · Filed May 29, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 78,236 |
Reported balance
After 2026-05-27 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-05-27 · Grant · Acquired 4,477 · Balance 78,236 F1: Represents an award of restricted stock units (RSUs) that is a contingent right to receive Class A Common Stock upon vesting. The RSUs are scheduled to vest on the earlier of the one-year anniversary of the date of grant or the day immediately preceding the date of the first annual meeting of the Issuer's stockholders occurring after the grant date. F2: The amount of shares reported herein reflects a 1-for-25 reverse stock split that was effected by the Issuer on March 26, 2026. F3: Includes 9,893 shares of Class A Common Stock received in a pro-rata distribution for no consideration, which was exempt from reporting pursuant to Rule 16a-9. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents an award of restricted stock units (RSUs) that is a contingent right to receive Class A Common Stock upon vesting. The RSUs are scheduled to vest on the earlier of the one-year anniversary of the date of grant or the day immediately preceding the date of the first annual meeting of the Issuer's stockholders occurring after the grant date.
F2: The amount of shares reported herein reflects a 1-for-25 reverse stock split that was effected by the Issuer on March 26, 2026.
F3: Includes 9,893 shares of Class A Common Stock received in a pro-rata distribution for no consideration, which was exempt from reporting pursuant to Rule 16a-9.
Conyers Park III Acquisition Corp.
Report date August 09, 2021 · Filed August 10, 2021
This filing explicitly reported no securities owned.
Nielsen Holdings plc
Report date June 16, 2017 · Filed June 20, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 11,411.495 |
Reported balance
After 2017-06-16 transaction · row 1
1 source rowRow 1 · 2017-06-16 · Grant · Acquired 100.283 · Balance 11,411.495 F1: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units.
PFIZER INC
Report date September 25, 2020 · Filed September 29, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom Stock UnitsSEC Table II · derivative / convertible security | Direct | 186,390.854 |
Reported balance
After 2020-09-25 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2020-09-25 · Grant · Acquired 953.537 · Balance 186,390.854 F1: Each unit represents one phantom share of common stock. F2: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. |
Filing footnotes · ownership attribution and instrument terms
F1: Each unit represents one phantom share of common stock.
F2: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors.
Simply Good Foods Co
Report date April 23, 2026 · Filed April 24, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 172,854 |
Reported balance
After 2026-04-23 transaction · row 1
1 source rowRow 1 · 2026-04-23 · Purchase · Acquired 80,000 · Balance 172,854 F1: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $12.24 to $12.50, inclusive. The reporting person undertakes to provide to the issuer, any stockholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. |
| Common StockSEC Table I · non-derivative | IndirectBy Limited Partnership | 2,715,513 |
Reported balance
Holding disclosure · report date 2026-04-23 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 2,715,513 F2: Represents shares held indirectly by an investment limited partnership of which the Reporting Person and his spouse are the co-general partners. |
| Common StockSEC Table I · non-derivative | IndirectBy LLC/Trusts | 895,157 |
Reported balance
Holding disclosure · report date 2026-04-23 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 895,157 F3: Represents shares of common stock held by an LLC owned by the Reporting Person and his spouse with passive interests in that LLC, owned by irrevocable family trusts, of which the Reporting Person and/or his spouse serve as trustees. The Reporting Person is the Manager of the LLC, and the Reporting Person continues to exercise investment control over the Reported Securities but disclaims beneficial ownership of the Reported Securities except to the extent of his pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $12.24 to $12.50, inclusive. The reporting person undertakes to provide to the issuer, any stockholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F2: Represents shares held indirectly by an investment limited partnership of which the Reporting Person and his spouse are the co-general partners.
F3: Represents shares of common stock held by an LLC owned by the Reporting Person and his spouse with passive interests in that LLC, owned by irrevocable family trusts, of which the Reporting Person and/or his spouse serve as trustees. The Reporting Person is the Manager of the LLC, and the Reporting Person continues to exercise investment control over the Reported Securities but disclaims beneficial ownership of the Reported Securities except to the extent of his pecuniary interest therein.
UNIFI INC
Report date October 27, 2021 · Filed October 29, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 37,201 |
Reported balance
After 2021-10-27 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2021-10-27 · Grant · Acquired 4,540 · Balance 37,201 F1: Represents a grant of restricted stock units from the issuer for services as a director of the issuer. The restricted stock units were fully vested on the date of grant and will be converted into an equivalent number of shares of common stock following the reporting person's termination of service as a director of the issuer. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a grant of restricted stock units from the issuer for services as a director of the issuer. The restricted stock units were fully vested on the date of grant and will be converted into an equivalent number of shares of common stock following the reporting person's termination of service as a director of the issuer.
Viatris Inc
Report date March 06, 2026 · Filed March 10, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 161,257 |
Ending reported balance
After 2026-03-06 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-03-06 · Exercise / conversion · Acquired 23,660 · Balance 160,082 Row 2 · 2026-03-06 · Exercise / conversion · Acquired 1,175 · Balance 161,257 F1: Fractional shares have been rounded up in connection with the settlement described in footnote 3 pursuant to the terms of the restricted stock unit (RSU) award agreement under the Viatris Inc. 2020 Stock Incentive Plan. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2026-03-06 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-03-06 · Exercise / conversion · Disposed 23,660 · Balance 0 F2: Each RSU represents the right to receive one share of common stock of Viatris Inc. These RSUs vested in full on March 6, 2026. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 15,890 |
Reported balance
After 2026-03-06 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-03-06 · Grant · Acquired 15,890 · Balance 15,890 F4: Each RSU represents the right to receive one share of common stock of Viatris Inc. These RSUs will vest on March 6, 2027. |
| Dividend Equivalent UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2026-03-06 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-03-06 · Exercise / conversion · Disposed 1,174.4921 · Balance 0 F3: Represents dividend equivalent units (DEUs) that accrued with respect to the RSUs previously granted on March 6, 2025 and vested on the same schedule as the underlying RSUs. Amount represents DEUs that accrued with respect to such RSUs in transactions exempt from Section 16 under Rule 16a-11. |
Filing footnotes · ownership attribution and instrument terms
F1: Fractional shares have been rounded up in connection with the settlement described in footnote 3 pursuant to the terms of the restricted stock unit (RSU) award agreement under the Viatris Inc. 2020 Stock Incentive Plan.
F2: Each RSU represents the right to receive one share of common stock of Viatris Inc. These RSUs vested in full on March 6, 2026.
F3: Represents dividend equivalent units (DEUs) that accrued with respect to the RSUs previously granted on March 6, 2025 and vested on the same schedule as the underlying RSUs. Amount represents DEUs that accrued with respect to such RSUs in transactions exempt from Section 16 under Rule 16a-11.
F4: Each RSU represents the right to receive one share of common stock of Viatris Inc. These RSUs will vest on March 6, 2027.
Past disclosures · reporting ended (3)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Conyers Park Acquisition Corp.
Report date July 07, 2017 · Filed July 12, 2017
Section 16 reporting ended · disclosed 2017-07-12. Current position is not established by this disclosure.
No balance rows disclosed in this filing.
METLIFE INC
Report date June 12, 2020 · Filed June 16, 2020
Section 16 reporting ended · disclosed 2020-06-16. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 80,509 |
Reported balance
After 2020-06-12 transaction · row 1
1 source rowRow 1 · 2020-06-12 · Grant · Acquired 718 · Balance 80,509 F1: Represents imputed reinvestment of dividends on deferred shares in the reporting person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred. |
| Common StockSEC Table I · non-derivative | Indirectby JMK Investments 2, LP | 236 |
Reported balance
Holding disclosure · report date 2020-06-12 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 236 F2: The reporting person disclaims beneficial ownership of 76.44% of shares held by JMK Investments 2, LP, representing limited partnership interests in trusts for the benefit of each of his children. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents imputed reinvestment of dividends on deferred shares in the reporting person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred.
F2: The reporting person disclaims beneficial ownership of 76.44% of shares held by JMK Investments 2, LP, representing limited partnership interests in trusts for the benefit of each of his children.
PROCTER & GAMBLE Co
Report date September 29, 2006 · Filed October 03, 2006
Section 16 reporting ended · disclosed 2006-10-03. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 158,842.922 |
Reported balance
After 2006-09-29 transaction · row 1
1 source rowRow 1 · 2006-09-29 · Grant · Acquired 150,000 · Balance 158,842.922 F1: Shares awarded pursuant to Reporting Person's Amended and Restated Employment Agreement as last amended (January 27, 2005). |
| Common StockSEC Table I · non-derivative | IndirectAtlas Heritage Foundation | 62,742.15 |
Reported balance
Holding disclosure · report date 2006-09-29 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 62,742.15 |
| Common StockSEC Table I · non-derivative | IndirectBy Daughter | 1,182.5 |
Reported balance
Holding disclosure · report date 2006-09-29 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 1,182.5 |
| Common StockSEC Table I · non-derivative | IndirectBy Son | 597.5 |
Reported balance
Holding disclosure · report date 2006-09-29 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 597.5 |
| Common StockSEC Table I · non-derivative | IndirectSavings Plan Trust-401(k) | 1,611.858 |
Reported balance
Holding disclosure · report date 2006-09-29 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 1,611.858 |
Filing footnotes · ownership attribution and instrument terms
F1: Shares awarded pursuant to Reporting Person's Amended and Restated Employment Agreement as last amended (January 27, 2005).
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 02, 2021 Filed Mar 4, 2021 23:35 UTC | Viatris Inc VTRS · Entity 3277 | GrantRestricted Stock Units · Derivative | 13,996 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-009925 · doc4.xml · derivative · entry 1 KILTS JAMES M · CIK 0001025094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,996 Underlying: Common Stock · 13,996 shares Expires not disclosed F1 · derivative.exercise_date: Each restricted stock unit (RSU) represents the right to receive one share of common stock of Viatris Inc. These RSUs will vest on March 2, 2022. F1 · derivative.expiration_date: Each restricted stock unit (RSU) represents the right to receive one share of common stock of Viatris Inc. These RSUs will vest on March 2, 2022. Read SEC document |
| December 16, 2020 Filed Dec 18, 2020 23:00 UTC | Viatris Inc VTRS · Entity 3277 | PurchaseCommon Stock | 27,736 | $17.66 | $489,692.95 |
DisclosureSEC source: 0000899243-20-034523 · doc4.xml · nonDerivative · entry 1 KILTS JAMES M · CIK 0001025094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,905 F1 · price: Represents the weighted average price of the reporting person's acquisition of 27,736 shares of common stock in transactions ranging from $17.57 to $17.73. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of common stock purchased at each separate price within the range set forth in this footnote. Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 00:46 UTC | Viatris Inc VTRS · Entity 3277 | GrantCommon Stock | 36,889 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-20-031560 · doc4.xml · nonDerivative · entry 1 KILTS JAMES M · CIK 0001025094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,169 F1 · security: On November 16, 2020, Mylan N.V. ("Mylan") completed the transaction pursuant to which Mylan combined with Pfizer Inc.'s ("Pfizer") Upjohn business (the "Upjohn Business") in a Reverse Morris Trust transaction (the "Combination") and Upjohn Inc. ("Upjohn") became the parent entity of the combined Upjohn Business and Mylan business and was renamed "Viatris Inc." ("Viatris"). Pursuant to the terms of the Business Combination Agreement (as amended), dated July 29, 2019, by and among Mylan, Pfizer, Upjohn and certain other affiliated entities, Upjohn and Mylan effected the Combination through a series of transactions, including that each holder of Mylan ordinary shares received one share of Viatris common stock for each Mylan ordinary share held by such holder (subject to any required withholding tax). F2 · price: Represents shares of Viatris common stock acquired in connection with the Combination on a one-for-one basis in exchange for ordinary shares of Mylan. On the effective date of the Combination, the closing price of a Mylan ordinary share was $15.85 per share. F3 · balance_after: Includes 280 shares of common stock acquired in the distribution on November 16, 2020 by Pfizer to its stockholders of all of the issued and outstanding shares of Upjohn common stock held by Pfizer by way of pro rata dividend. Read SEC document |
| November 16, 2020 Filed Sep 23, 2022 22:00 UTC Amendment | Viatris Inc VTRS · Entity 3277 | GrantCommon Stock | 35,764 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-031922 · doc4a.xml · nonDerivative · entry 1 KILTS JAMES M · CIK 0001025094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,044 F1 · security: On November 16, 2020, Mylan N.V. ("Mylan") completed the transaction pursuant to which Mylan combined with Pfizer Inc.'s ("Pfizer") Upjohn business (the "Upjohn Business") in a Reverse Morris Trust transaction (the "Combination") and Upjohn Inc. ("Upjohn") became the parent entity of the combined Upjohn Business and Mylan business and was renamed "Viatris Inc." ("Viatris"). Pursuant to the terms of the Business Combination Agreement (as amended), dated July 29, 2019, by and among Mylan, Pfizer, Upjohn and certain other affiliated entities, Upjohn and Mylan effected the Combination through a series of transactions, including that each holder of Mylan ordinary shares received one share of Viatris common stock for each Mylan ordinary share held by such holder (subject to any required withholding tax). F2 · price: Represents shares of Viatris common stock acquired in connection with the Combination on a one-for-one basis in exchange for ordinary shares of Mylan. On the effective date of the Combination, the closing price of a Mylan ordinary share was $15.85 per share. F3 · balance_after: Includes 280 shares of common stock acquired in the distribution on November 16, 2020 by Pfizer to its stockholders of all of the issued and outstanding shares of Upjohn common stock held by Pfizer by way of pro rata dividend. Read SEC document |
| October 28, 2020 Filed Oct 30, 2020 20:05 UTC | UNIFI INC UFI · Entity 6574 | GrantCommon Stock | 6,285 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-20-009000 · marketforms-49940.xml · nonDerivative · entry 1 KILTS JAMES M · CIK 0001025094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,661 F1 · security: Represents a grant of restricted stock units from the issuer for services as a director of the issuer. The restricted stock units were fully vested as of the reporting person's election as a director of the issuer on October 29, 2020 and will be converted into an equivalent number of shares of common stock following the reporting person's termination of service as a director of the issuer. Read SEC document |
| September 25, 2020 Filed Sep 29, 2020 00:29 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units · Derivative | 953.537 | $36.05 | $34,375.01 |
DisclosureSEC source: 0001225208-20-011858 · doc4.xml · derivative · entry 1 KILTS JAMES M · CIK 0001025094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 186,390.854 Underlying: Common Stock · 953.537 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. Read SEC document |
| September 06, 2020 Filed Sep 8, 2020 23:02 UTC | Simply Good Foods Co SMPL · Entity 4946 | GrantCommon Stock | 4,222 | $0.00 | $0.00 |
DisclosureSEC source: 0001702744-20-000083 · wf-form4_159960615195727.xml · nonDerivative · entry 1 KILTS JAMES M · CIK 0001025094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 965,490 F1 · shares: Represents restricted stock units ("RSUs") granted under the issuer's 2017 Omnibus Incentive Plan. Each RSU represents the contingent right to receive one share of the issuer's common stock. The RSUs vest on the first anniversary of the grant date. Read SEC document |
| June 26, 2020 Filed Jul 2, 2020 01:12 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units · Derivative | 1,072.878 | $32.04 | $34,375.01 |
DisclosureSEC source: 0001225208-20-009245 · doc4.xml · derivative · entry 1 KILTS JAMES M · CIK 0001025094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 183,546.115 Underlying: Common Stock · 1,072.878 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. Read SEC document |
| June 12, 2020 Filed Jun 16, 2020 20:59 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 718 | $37.45 | $26,889.10 |
DisclosureSEC source: 0001099219-20-000240 · wf-form4_159234112530918.xml · nonDerivative · entry 1 KILTS JAMES M · CIK 0001025094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,509 F1 · kind: Represents imputed reinvestment of dividends on deferred shares in the reporting person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred. Read SEC document |
| May 18, 2020 Filed May 19, 2020 21:00 UTC | UNIFI INC UFI · Entity 6574 | PurchaseCommon Stock | 100 | $11.98 | $1,198.00 |
DisclosureSEC source: 0001214659-20-004816 · marketforms-48825.xml · nonDerivative · entry 2 KILTS JAMES M · CIK 0001025094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,376 Read SEC document |
| May 15, 2020 Filed May 19, 2020 21:00 UTC | UNIFI INC UFI · Entity 6574 | PurchaseCommon Stock | 2,700 | $11.91 | $32,157.00 |
DisclosureSEC source: 0001214659-20-004816 · marketforms-48825.xml · nonDerivative · entry 1 KILTS JAMES M · CIK 0001025094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,276 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.82 to $12.00, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| April 28, 2020 Filed Apr 29, 2020 13:04 UTC | Simply Good Foods Co SMPL · Entity 4946 | PurchaseCommon Stock | 87,862 | $16.88 | $1,483,374.15 |
DisclosureSEC source: 0001702744-20-000043 · wf-form4_158816544980036.xml · nonDerivative · entry 1 KILTS JAMES M · CIK 0001025094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 961,268 F1 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $16.76 to $17.00, inclusive. The reporting person undertakes to provide to the issuer, any stockholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| April 23, 2020 Filed Apr 24, 2020 19:38 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units · Derivative | 5,246.661 | $36.69 | $192,499.99 |
DisclosureSEC source: 0001225208-20-006709 · doc4.xml · derivative · entry 1 KILTS JAMES M · CIK 0001025094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,566.726 Underlying: Common Stock · 5,246.661 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · shares: Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors. F3 · derivative.exercise_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. F3 · derivative.expiration_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. Read SEC document |
| April 15, 2020 Filed Apr 16, 2020 01:10 UTC | Simply Good Foods Co SMPL · Entity 4946 | PurchaseCommon Stock | 32,507 | $16.57 | $538,699.50 |
DisclosureSEC source: 0001702744-20-000041 · wf-form4_158699938875280.xml · nonDerivative · entry 2 KILTS JAMES M · CIK 0001025094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 873,406 F2 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $16.31 to $17.00, inclusive. The reporting person undertakes to provide to the issuer, any stockholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| April 14, 2020 Filed Apr 16, 2020 01:10 UTC | Simply Good Foods Co SMPL · Entity 4946 | PurchaseCommon Stock | 14,582 | $16.76 | $244,422.03 |
DisclosureSEC source: 0001702744-20-000041 · wf-form4_158699938875280.xml · nonDerivative · entry 1 KILTS JAMES M · CIK 0001025094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 840,899 F1 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $16.44 to $16.90, inclusive. The reporting person undertakes to provide to the issuer, any stockholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| April 01, 2020 Filed Apr 2, 2020 21:21 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 1,345 | $27.90 | $37,525.50 |
DisclosureSEC source: 0001099219-20-000180 · wf-form4_158586244779327.xml · nonDerivative · entry 1 KILTS JAMES M · CIK 0001025094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,791 F1 · kind: The reporting person acquired these deferred shares under MetLife, Inc.'s non-management director compensation arrangements, which provide for 50% of non-management director retainer fees to be paid in MetLife, Inc. common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which directors may elect to defer receipt of such stock for a specified period of time. Read SEC document |
| March 27, 2020 Filed Mar 30, 2020 22:25 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units · Derivative | 1,112.46 | $30.90 | $34,375.01 |
DisclosureSEC source: 0001225208-20-005676 · doc4.xml · derivative · entry 1 KILTS JAMES M · CIK 0001025094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,320.065 Underlying: Common Stock · 1,112.46 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. Read SEC document |
| March 13, 2020 Filed Mar 18, 2020 01:13 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 777 | $31.93 | $24,809.61 |
DisclosureSEC source: 0001099219-20-000161 · wf-form4_158449401457588.xml · nonDerivative · entry 1 KILTS JAMES M · CIK 0001025094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,446 F1 · kind: Represents imputed reinvestment of dividends on deferred shares in the reporting person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred. Read SEC document |
| February 24, 2020 Filed Feb 24, 2020 22:18 UTC | Simply Good Foods Co SMPL · Entity 4946 | PurchaseCommon Stock | 88,500 | $22.54 | $1,994,639.55 |
DisclosureSEC source: 0001702744-20-000017 · wf-form4_158258270870046.xml · nonDerivative · entry 1 KILTS JAMES M · CIK 0001025094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 826,317 F1 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $22.32 to $22.75, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| January 14, 2020 Filed Jan 16, 2020 23:05 UTC | Simply Good Foods Co SMPL · Entity 4946 | PurchaseCommon Stock | 600 | $23.11 | $13,867.98 |
DisclosureSEC source: 0001702744-20-000010 · wf-form4_157921589343775.xml · nonDerivative · entry 1 KILTS JAMES M · CIK 0001025094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 737,817 F1 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $23.10 to $23.15, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:50 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 727 | $51.62 | $37,527.74 |
DisclosureSEC source: 0001099219-20-000044 · wf-form4_157834741534870.xml · nonDerivative · entry 1 KILTS JAMES M · CIK 0001025094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,669 F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in MetLife, Inc. common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specified period of time. Read SEC document |
| December 31, 2019 Filed Jan 2, 2020 23:36 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units · Derivative | 877.361 | $39.18 | $34,375.00 |
DisclosureSEC source: 0001225208-20-000055 · doc4.xml · derivative · entry 1 KILTS JAMES M · CIK 0001025094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 172,337.58 Underlying: Common Stock · 877.361 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. Read SEC document |
| December 16, 2019 Filed Dec 17, 2019 22:00 UTC | METLIFE INC MET · Entity 488 | OtherDeferred Share Equivalents · Derivative | 11,917 | $50.48 | $601,570.16 |
DisclosureSEC source: 0001099219-19-000261 · wf-form4_157662001951650.xml · derivative · entry 4 KILTS JAMES M · CIK 0001025094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,917 shares Expires not disclosed F3 · derivative.exercise_price: Each Deferred Share Equivalent is the economic value of one share of MetLife, Inc. common stock. Deferred Share Equivalents were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Deferred Share Equivalents are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F5 · kind: The Issuer eliminated the opportunity to acquire Deferred Share Equivalents under the MetLife Deferred Compensation Plan for Non-Management Directors and transferred the cash amount representing the Reporting Person's Deferred Share Equivalents into a simulated investment that does not track MetLife, Inc. securities. F5 · price: The Issuer eliminated the opportunity to acquire Deferred Share Equivalents under the MetLife Deferred Compensation Plan for Non-Management Directors and transferred the cash amount representing the Reporting Person's Deferred Share Equivalents into a simulated investment that does not track MetLife, Inc. securities. F3 · derivative.exercise_date: Each Deferred Share Equivalent is the economic value of one share of MetLife, Inc. common stock. Deferred Share Equivalents were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Deferred Share Equivalents are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F3 · derivative.expiration_date: Each Deferred Share Equivalent is the economic value of one share of MetLife, Inc. common stock. Deferred Share Equivalents were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Deferred Share Equivalents are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. Read SEC document |
| December 13, 2019 Filed Dec 17, 2019 22:00 UTC | METLIFE INC MET · Entity 488 | GrantDeferred Share Equivalents · Derivative | 103 | $50.38 | $5,189.14 |
DisclosureSEC source: 0001099219-19-000261 · wf-form4_157662001951650.xml · derivative · entry 3 KILTS JAMES M · CIK 0001025094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,917 Underlying: Common Stock · 103 shares Expires not disclosed F3 · derivative.exercise_price: Each Deferred Share Equivalent is the economic value of one share of MetLife, Inc. common stock. Deferred Share Equivalents were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Deferred Share Equivalents are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F4 · kind: Represents imputed reinvestment of dividends on Deferred Share Equivalents. F4 · timeliness: Represents imputed reinvestment of dividends on Deferred Share Equivalents. F3 · derivative.exercise_date: Each Deferred Share Equivalent is the economic value of one share of MetLife, Inc. common stock. Deferred Share Equivalents were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Deferred Share Equivalents are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F3 · derivative.expiration_date: Each Deferred Share Equivalent is the economic value of one share of MetLife, Inc. common stock. Deferred Share Equivalents were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Deferred Share Equivalents are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. Read SEC document |
| December 13, 2019 Filed Dec 17, 2019 22:00 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 485 | $50.38 | $24,434.30 |
DisclosureSEC source: 0001099219-19-000261 · wf-form4_157662001951650.xml · nonDerivative · entry 1 KILTS JAMES M · CIK 0001025094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,942 F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred. Read SEC document |
| November 13, 2019 Filed Nov 15, 2019 02:58 UTC | Simply Good Foods Co SMPL · Entity 4946 | PurchaseCommon Stock | 70,000 | $24.62 | $1,723,400.00 |
DisclosureSEC source: 0001104659-19-064469 · a4.xml · nonDerivative · entry 1 KILTS JAMES M · CIK 0001025094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 737,217 F1 · shares: Reflects shares of common stock of the issuer acquired by the Reporting Person, in a privately negotiated transaction, from an entity to which Conyers Park Sponsor LLC previously transferred such shares (as disclosed in a Statement of Changes in Beneficial Ownership on Form 4 filed by Conyers Park Sponsor LLC, dated November 14, 2019). Read SEC document |
| November 08, 2019 Filed Nov 13, 2019 21:09 UTC | Simply Good Foods Co SMPL · Entity 4946 | PurchaseCommon Stock | 313 | $23.82 | $7,455.66 |
DisclosureSEC source: 0001628280-19-014098 · wf-form4_157367936826731.xml · nonDerivative · entry 1 KILTS JAMES M · CIK 0001025094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 667,217 F1 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $23.80 to $23.82, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| October 30, 2019 Filed Nov 1, 2019 21:00 UTC | UNIFI INC UFI · Entity 6574 | GrantCommon Stock | 1,842 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-19-006793 · marketforms-46037.xml · nonDerivative · entry 1 KILTS JAMES M · CIK 0001025094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,576 F1 · security: Represents a grant of common stock from the issuer for services as a director of the issuer. Read SEC document |
| October 01, 2019 Filed Oct 3, 2019 20:48 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 815 | $46.03 | $37,514.45 |
DisclosureSEC source: 0001099219-19-000212 · wf-form4_157013567086554.xml · nonDerivative · entry 1 KILTS JAMES M · CIK 0001025094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,457 F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specified period of time. Read SEC document |
| September 27, 2019 Filed Oct 1, 2019 20:19 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units · Derivative | 949.061 | $36.22 | $34,374.99 |
DisclosureSEC source: 0001225208-19-012895 · doc4.xml · derivative · entry 1 KILTS JAMES M · CIK 0001025094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,863.177 Underlying: Common Stock · 949.061 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. Read SEC document |
| September 13, 2019 Filed Sep 17, 2019 20:56 UTC | METLIFE INC MET · Entity 488 | GrantDeferred Share Equivalents · Derivative | 106 | $48.37 | $5,127.22 |
DisclosureSEC source: 0001099219-19-000175 · wf-form4_156875379587820.xml · derivative · entry 3 KILTS JAMES M · CIK 0001025094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,814 Underlying: Common Stock · 106 shares Expires not disclosed F3 · derivative.exercise_price: Each Deferred Share Equivalent is the economic value of one share of MetLife, Inc. common stock. Deferred Share Equivalents were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Deferred Share Equivalents are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F4 · kind: Represents imputed reinvestment of dividends on Deferred Share Equivalents. F4 · timeliness: Represents imputed reinvestment of dividends on Deferred Share Equivalents. F3 · price: Each Deferred Share Equivalent is the economic value of one share of MetLife, Inc. common stock. Deferred Share Equivalents were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Deferred Share Equivalents are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F3 · derivative.exercise_date: Each Deferred Share Equivalent is the economic value of one share of MetLife, Inc. common stock. Deferred Share Equivalents were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Deferred Share Equivalents are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F3 · derivative.expiration_date: Each Deferred Share Equivalent is the economic value of one share of MetLife, Inc. common stock. Deferred Share Equivalents were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Deferred Share Equivalents are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. Read SEC document |
| September 13, 2019 Filed Sep 17, 2019 20:56 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 493 | $48.37 | $23,846.41 |
DisclosureSEC source: 0001099219-19-000175 · wf-form4_156875379587820.xml · nonDerivative · entry 1 KILTS JAMES M · CIK 0001025094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,642 F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred. Read SEC document |
| September 06, 2019 Filed Sep 10, 2019 20:10 UTC | Simply Good Foods Co SMPL · Entity 4946 | GrantCommon Stock | 3,011 | $0.00 | $0.00 |
DisclosureSEC source: 0001702744-19-000033 · wf-form4_156814624149016.xml · nonDerivative · entry 1 KILTS JAMES M · CIK 0001025094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 666,904 F1 · shares: Represents restricted stock units ("RSUs") granted under the issuer's 2017 Omnibus Incentive Plan. Each RSU represents the contingent right to receive one share of the issuer's common stock. The RSUs vest on the first anniversary of the grant date Read SEC document |
| June 28, 2019 Filed Jul 2, 2019 00:55 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units · Derivative | 793.51 | $43.32 | $34,374.85 |
DisclosureSEC source: 0001225208-19-009714 · doc4.xml · derivative · entry 1 KILTS JAMES M · CIK 0001025094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 167,247.2 Underlying: Common Stock · 793.51 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. Read SEC document |
| June 18, 2019 Filed Jun 20, 2019 20:53 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 770 | $48.71 | $37,506.70 |
DisclosureSEC source: 0001099219-19-000123 · wf-form4_156106400563592.xml · nonDerivative · entry 1 KILTS JAMES M · CIK 0001025094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,149 F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specified period of time. Read SEC document |
| June 13, 2019 Filed Jun 17, 2019 23:02 UTC | METLIFE INC MET · Entity 488 | GrantDeferred Share Equivalents · Derivative | 105 | $48.51 | $5,093.55 |
DisclosureSEC source: 0001099219-19-000078 · wf-form4_156081256213303.xml · derivative · entry 3 KILTS JAMES M · CIK 0001025094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,707 Underlying: Common Stock · 105 shares Expires not disclosed F3 · derivative.exercise_price: Each Deferred Share Equivalent is the economic value of one share of MetLife, Inc. common stock. Deferred Share Equivalents were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Deferred Share Equivalents are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F4 · kind: Represents imputed reinvestment of dividends on Deferred Share Equivalents. F4 · timeliness: Represents imputed reinvestment of dividends on Deferred Share Equivalents. F3 · price: Each Deferred Share Equivalent is the economic value of one share of MetLife, Inc. common stock. Deferred Share Equivalents were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Deferred Share Equivalents are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F3 · derivative.exercise_date: Each Deferred Share Equivalent is the economic value of one share of MetLife, Inc. common stock. Deferred Share Equivalents were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Deferred Share Equivalents are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F3 · derivative.expiration_date: Each Deferred Share Equivalent is the economic value of one share of MetLife, Inc. common stock. Deferred Share Equivalents were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Deferred Share Equivalents are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F5 · balance_after: Deferred Share Equivalents were previously referred to as "Common Stock Equivalent Units." Beginning with this report, the Reporting Person will report the total of all the person's Deferred Share Equivalents in Table II Box 9. Read SEC document |
| June 13, 2019 Filed Jun 17, 2019 23:02 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 480 | $48.51 | $23,284.80 |
DisclosureSEC source: 0001099219-19-000078 · wf-form4_156081256213303.xml · nonDerivative · entry 1 KILTS JAMES M · CIK 0001025094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,379 F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred. Read SEC document |
| April 25, 2019 Filed Apr 26, 2019 21:31 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units · Derivative | 4,859.884 | $39.61 | $192,500.01 |
DisclosureSEC source: 0001225208-19-007235 · doc4.xml · derivative · entry 1 KILTS JAMES M · CIK 0001025094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,069.14 Underlying: Common Stock · 4,859.884 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · shares: Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors. F3 · derivative.exercise_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election, following the reporting person's retirement from the Board of Directors. F3 · derivative.expiration_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election, following the reporting person's retirement from the Board of Directors. Read SEC document |
| April 01, 2019 Filed Apr 2, 2019 20:42 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 850 | $44.13 | $37,510.50 |
DisclosureSEC source: 0001209191-19-022567 · doc4.xml · nonDerivative · entry 1 KILTS JAMES M · CIK 0001025094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,899 F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specified period of time. Read SEC document |
| March 29, 2019 Filed Apr 1, 2019 23:00 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units · Derivative | 809.395 | $42.47 | $34,375.01 |
DisclosureSEC source: 0001225208-19-005958 · doc4.xml · derivative · entry 1 KILTS JAMES M · CIK 0001025094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,209.256 Underlying: Common Stock · 809.395 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. Read SEC document |
| March 13, 2019 Filed Mar 14, 2019 20:44 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock Equivalent Units · Derivative | 108 | $44.70 | $4,827.60 |
DisclosureSEC source: 0001209191-19-019484 · doc4.xml · derivative · entry 3 KILTS JAMES M · CIK 0001025094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108 Underlying: Common Stock · 108 shares Expires not disclosed F3 · derivative.exercise_price: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F4 · timeliness: Represents imputed reinvestment of dividends on Common Stock Equivalent Units. F3 · price: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F3 · derivative.exercise_date: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F3 · derivative.expiration_date: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. Read SEC document |
| March 13, 2019 Filed Mar 14, 2019 20:44 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 485 | $44.70 | $21,679.50 |
DisclosureSEC source: 0001209191-19-019484 · doc4.xml · nonDerivative · entry 1 KILTS JAMES M · CIK 0001025094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,049 F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 21:39 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 900 | $41.67 | $37,503.00 |
DisclosureSEC source: 0001209191-19-002009 · doc4.xml · nonDerivative · entry 1 KILTS JAMES M · CIK 0001025094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,564.2347 F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specified period of time. Read SEC document |
| December 31, 2018 Filed Jan 2, 2019 22:36 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units · Derivative | 787.514 | $43.65 | $34,374.99 |
DisclosureSEC source: 0001225208-19-000133 · doc4.xml · derivative · entry 1 KILTS JAMES M · CIK 0001025094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,087.328 Underlying: Common Stock · 787.514 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. Read SEC document |
| December 13, 2018 Filed Dec 14, 2018 21:29 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock Equivalent Units · Derivative | 120.8696 | $39.52 | $4,776.77 |
DisclosureSEC source: 0001209191-18-062730 · doc4.xml · derivative · entry 3 KILTS JAMES M · CIK 0001025094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120.8696 Underlying: Common Stock · 120.8696 shares Expires not disclosed F3 · derivative.exercise_price: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F4 · timeliness: Represents imputed reinvestment of dividends on Common Stock Equivalent Units. F3 · price: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F3 · derivative.exercise_date: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F3 · derivative.expiration_date: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. Read SEC document |
| December 13, 2018 Filed Dec 14, 2018 21:29 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 536.8958 | $39.52 | $21,218.12 |
DisclosureSEC source: 0001209191-18-062730 · doc4.xml · nonDerivative · entry 1 KILTS JAMES M · CIK 0001025094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,664.2347 F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred. Read SEC document |
| October 31, 2018 Filed Nov 2, 2018 20:15 UTC | UNIFI INC UFI · Entity 6574 | GrantCommon Stock | 6,446 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-18-006840 · marketforms-43116.xml · nonDerivative · entry 1 KILTS JAMES M · CIK 0001025094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,734 F1 · security: Represents a grant of common stock from the issuer for services as a director of the issuer pursuant to the issuer's director compensation policy. Read SEC document |
| October 01, 2018 Filed Oct 3, 2018 21:32 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 802 | $46.77 | $37,509.54 |
DisclosureSEC source: 0001209191-18-054018 · doc4.xml · nonDerivative · entry 1 KILTS JAMES M · CIK 0001025094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,127.3389 F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specified period of time. Read SEC document |
| September 28, 2018 Filed Oct 1, 2018 20:19 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units · Derivative | 780.009 | $44.07 | $34,375.00 |
DisclosureSEC source: 0001225208-18-013900 · doc4.xml · derivative · entry 1 KILTS JAMES M · CIK 0001025094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,145.444 Underlying: Common Stock · 780.009 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors. Read SEC document |
| September 13, 2018 Filed Sep 17, 2018 21:02 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock Equivalent Units · Derivative | 103.9783 | $45.52 | $4,733.09 |
DisclosureSEC source: 0001209191-18-051248 · doc4.xml · derivative · entry 3 KILTS JAMES M · CIK 0001025094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103.9783 Underlying: Common Stock · 103.9783 shares Expires not disclosed F3 · derivative.exercise_price: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F4 · timeliness: Represents imputed reinvestment of dividends on Common Stock Equivalent Units. F3 · price: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F3 · derivative.exercise_date: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. F3 · derivative.expiration_date: Each Common Stock Equivalent Unit is the economic value of one share of MetLife, Inc. common stock. Common Stock Equivalent Units were acquired pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors, whereby Directors may elect to defer receipt of cash retainer fees for a specified period of time into a fund that tracks MetLife, Inc. common stock. Common Stock Equivalent Units are settled in cash. Directors may transfer deferred cash retainer fees out of the fund that tracks MetLife, Inc. common stock and into other simulated investments. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.